Daniel J. Burge
Daniel J. Burge publishes mostly in Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging, on topics such as Psoriasis: Treatment and Pathogenesis, Rheumatoid Arthritis Research and Therapies and Monoclonal and Polyclonal Antibodies Research.
- World rank
- #825,747 of 7,710,434 ranked researchers
- Rank in United States
- #274,728 of 1,627,098
- Works
- 32
- Citations
- 5.1k
- Citations per work
- 160.1
What does Daniel J. Burge research?
Daniel J. Burge's work is mostly in Medicine (50%), Immunology and Microbiology (23%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1650.0%
- Medicine1650.0%
- Everything else927.3%
- Life Sciences722.7%
- 1Rheumatology26% of their works
- 2Immunology23% of their works
- 3Radiology, Nuclear Medicine and Imaging8% of their works
- 4Hematology6% of their works
- 5Pediatrics, Perinatology and Child Health6% of their works
- 6Pathology and Forensic Medicine4% of their works
Research topics
- Psoriasis: Treatment and Pathogenesis
- Rheumatoid Arthritis Research and Therapies
- Monoclonal and Polyclonal Antibodies Research
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
- Autoimmune and Inflammatory Disorders Research
- Pharmaceutical studies and practices
- Autoimmune Bullous Skin Diseases
Which keywords describe Daniel J. Burge's research?
The keywords of their largest research topics: Autoantibodies, IL-17, TH17 Cells, Inflammation, Rheumatoid Arthritis, Ankylosing Spondylitis, Fc Receptors and Spondyloarthritis.
- Pemphigoid
- Off-Label Drug Use
- Hemophagocytic Lymphohistiocytosis
- Antiphospholipid Syndrome
- Spondyloarthritis
- Ankylosing Spondylitis
- Inflammation
- IL-17
- Autoantibodies
- TH17 Cells
- Rheumatoid Arthritis
- Fc Receptors
- Therapeutic Antibodies
- Systemic Lupus Erythematosus
- Juvenile Idiopathic Arthritis
- Pediatric Pharmacokinetics
- Rituximab
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Autoantibodies203 topics
- IL-17131 topic
- TH17 Cells131 topic
- Inflammation101 topic
- Rheumatoid Arthritis101 topic
- Ankylosing Spondylitis71 topic
- Fc Receptors71 topic
- Spondyloarthritis71 topic
- Therapeutic Antibodies71 topic
- Antiphospholipid Syndrome61 topic
- Systemic Lupus Erythematosus61 topic
- Hemophagocytic Lymphohistiocytosis51 topic
- Juvenile Idiopathic Arthritis51 topic
- Off-Label Drug Use51 topic
- Pediatric Pharmacokinetics51 topic
- Pemphigoid41 topic
- Rituximab41 topic
Where does Daniel J. Burge work?
Daniel J. Burge's main affiliation in the publication record is Resolve Therapeutics (United States), United States.
How many publications and citations does Daniel J. Burge have?
OpenAlex counts 32 works and 5,124 citations for Daniel J. Burge, an h-index of 16, ranking #825,747 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Daniel J. Burge
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Daniel J. Burge. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.